Browse by Series:

FDA Approval in ALL, Priority Reviews in CML and Breast Cancer, and More

Gina Columbus
Published: Monday, Jul 17, 2017



Gina Columbus reports on an FDA approval in acute lymphoblastic leukemia, priority reviews in chronic myeloid leukemia and breast cancer, ODAC recommendations in ALL and and acute myeloid leukemia, and a clinical hold on 3 multiple myeloma trials.
SELECTED
LANGUAGE
Slider Left
Slider Right


Gina Columbus reports on an FDA approval in acute lymphoblastic leukemia, priority reviews in chronic myeloid leukemia and breast cancer, ODAC recommendations in ALL and and acute myeloid leukemia, and a clinical hold on 3 multiple myeloma trials.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How to Use Liquid Biopsies Throughout the Lung Cancer Treatment Continuum OnlineJan 31, 20191.5
Community Practice Connections™: Current Status and the Future Potential of CAR T-Cell Therapy for Lymphoid Malignancies: The Experts Weigh-In on Recent Data and Clinical ExperienceJan 31, 20192.0
Publication Bottom Border
Border Publication
x